The post Metaplanet Seeks New Funding amid Stock Decline appeared on BitcoinEthereumNews.com. Key Points: Metaplanet faces a stock decline and revises its funding strategy. Erik Trump involved as advisor with 3.3 million shares. Preferred share issuance could inject $3.7 billion USD. Metaplanet, a Tokyo-listed Bitcoin holding company, has experienced a 54% stock price drop since mid-June, prompting a shift in financing strategy to public overseas share offerings. This significant move highlights the challenges in maintaining capital momentum for BTC accumulation amidst market volatility, posing potential dilution and strategic concerns for investors. Metaplanet’s Strategic Moves Amid 54% Stock Decline Metaplanet’s stock price experienced a significant drop of 54%, prompting changes in strategy. Leadership emphasizes international reach, engaging figures like Simon Gerovich and Eric Trump to elevate the company’s visibility and executive strength. The shift in strategy involves substantial overseas shares and potential issuance of rare preferred shares in Japan. Metaplanet aims to raise 130.3 billion yen for further Bitcoin acquisition. The global market has responded with diverse reactions. There are positive sentiments on platforms, suggesting confidence in Bitcoin acquisitions. Regulators and industry voices remain relatively silent on Metaplanet’s extensive actions. As Simon Gerovich, CEO of Metaplanet, asserted, “We are pivoting our capital strategy to seek substantial funding to expand our BTC treasury holdings aggressively.” Bitcoin Acquisition Plans and Market Outlook Did you know? Metaplanet employs a rare financial tool in Japan by raising funds through preferred shares, enhancing its strategic alignment with global peers. As of August 31, 2025, Bitcoin (BTC) is valued at $108,981.94 with a market cap of $2.17 trillion, according to CoinMarketCap. Despite a minimal 24-hour increase of 0.16%, the broader outlook shows a 4.65% decrease over the week, reflecting the asset’s various market pressures. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:08 UTC on August 31, 2025. Source: CoinMarketCap Insights from the Coincu research team suggest regulatory tolerance in… The post Metaplanet Seeks New Funding amid Stock Decline appeared on BitcoinEthereumNews.com. Key Points: Metaplanet faces a stock decline and revises its funding strategy. Erik Trump involved as advisor with 3.3 million shares. Preferred share issuance could inject $3.7 billion USD. Metaplanet, a Tokyo-listed Bitcoin holding company, has experienced a 54% stock price drop since mid-June, prompting a shift in financing strategy to public overseas share offerings. This significant move highlights the challenges in maintaining capital momentum for BTC accumulation amidst market volatility, posing potential dilution and strategic concerns for investors. Metaplanet’s Strategic Moves Amid 54% Stock Decline Metaplanet’s stock price experienced a significant drop of 54%, prompting changes in strategy. Leadership emphasizes international reach, engaging figures like Simon Gerovich and Eric Trump to elevate the company’s visibility and executive strength. The shift in strategy involves substantial overseas shares and potential issuance of rare preferred shares in Japan. Metaplanet aims to raise 130.3 billion yen for further Bitcoin acquisition. The global market has responded with diverse reactions. There are positive sentiments on platforms, suggesting confidence in Bitcoin acquisitions. Regulators and industry voices remain relatively silent on Metaplanet’s extensive actions. As Simon Gerovich, CEO of Metaplanet, asserted, “We are pivoting our capital strategy to seek substantial funding to expand our BTC treasury holdings aggressively.” Bitcoin Acquisition Plans and Market Outlook Did you know? Metaplanet employs a rare financial tool in Japan by raising funds through preferred shares, enhancing its strategic alignment with global peers. As of August 31, 2025, Bitcoin (BTC) is valued at $108,981.94 with a market cap of $2.17 trillion, according to CoinMarketCap. Despite a minimal 24-hour increase of 0.16%, the broader outlook shows a 4.65% decrease over the week, reflecting the asset’s various market pressures. Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:08 UTC on August 31, 2025. Source: CoinMarketCap Insights from the Coincu research team suggest regulatory tolerance in…

Metaplanet Seeks New Funding amid Stock Decline

Key Points:
  • Metaplanet faces a stock decline and revises its funding strategy.
  • Erik Trump involved as advisor with 3.3 million shares.
  • Preferred share issuance could inject $3.7 billion USD.

Metaplanet, a Tokyo-listed Bitcoin holding company, has experienced a 54% stock price drop since mid-June, prompting a shift in financing strategy to public overseas share offerings.

This significant move highlights the challenges in maintaining capital momentum for BTC accumulation amidst market volatility, posing potential dilution and strategic concerns for investors.

Metaplanet’s Strategic Moves Amid 54% Stock Decline

Metaplanet’s stock price experienced a significant drop of 54%, prompting changes in strategy. Leadership emphasizes international reach, engaging figures like Simon Gerovich and Eric Trump to elevate the company’s visibility and executive strength.

The shift in strategy involves substantial overseas shares and potential issuance of rare preferred shares in Japan. Metaplanet aims to raise 130.3 billion yen for further Bitcoin acquisition.

The global market has responded with diverse reactions. There are positive sentiments on platforms, suggesting confidence in Bitcoin acquisitions. Regulators and industry voices remain relatively silent on Metaplanet’s extensive actions. As Simon Gerovich, CEO of Metaplanet, asserted, “We are pivoting our capital strategy to seek substantial funding to expand our BTC treasury holdings aggressively.”

Bitcoin Acquisition Plans and Market Outlook

Did you know? Metaplanet employs a rare financial tool in Japan by raising funds through preferred shares, enhancing its strategic alignment with global peers.

As of August 31, 2025, Bitcoin (BTC) is valued at $108,981.94 with a market cap of $2.17 trillion, according to CoinMarketCap. Despite a minimal 24-hour increase of 0.16%, the broader outlook shows a 4.65% decrease over the week, reflecting the asset’s various market pressures.

Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 18:08 UTC on August 31, 2025. Source: CoinMarketCap

Insights from the Coincu research team suggest regulatory tolerance in Japan may grow, encouraging innovative financial strategies. This opens up paths for technological advancements and affirms Bitcoin’s continuing global economic role.

Source: https://coincu.com/markets/metaplanet-new-funding-bid/

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$5.348
$5.348$5.348
-1.56%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26